Iterum Therapeutics (ITRM) Q2 2025 Earnings

May 13Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.45
-0.33
-0.22
-0.1

Details

Expected EPS
-0.14
Actual EPS
-0.1
Surprise EPS
0.04
Surprise Percent
+28.57%

Description

⁨Iterum Therapeutics⁩ (⁦ITRM⁩) has reported earnings of ⁦-0.1⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts